shortage

Leading drug makers and pharmaceutical companies are having little luck addressing nationwide shortages of stimulant-based ADHD medications like Adderall, Vyvanse and Ritalin. Unfortunately for patients, the shortage does not appear to be any closer to a resolution than when it started almost a year ago.